- "There was and there is no takeover offer from the White House or governmental authorities. Neither to the technology or to CureVac at all as a company," CureVac acting CEO Franz-Wener Haas said on a conference call on Tuesday.
- Visit Business Insider's homepage for more stories .
'There was and there is no takeover offer': German coronavirus vaccine company CureVac is shooting down viral reports that Trump tried to buy it
The German biotech company CureVac is denying reports that Trump administration officials attempted to acquire the company.
The Gerrman biotech company working on a coronavirus vaccine has denied reports that the Trump administration made moves to acquire the firm or its research.
CureVac has been shooting down the news reports for several days, and added to the denials in a conference call with investors on Tuesday.
"There was and there is no takeover offer from the White House or governmental authorities. Neither to the technology or to CureVac at all as a company," CureVac acting CEO Franz-Wener Haas said on a conference call on Tuesday.
CureVac gained widespread attention over the weekend after the German newspaper Welt am Sonntag reported that a Trump administration official offered large sums of money for rights to its vaccine, "but only for the USA."
Read more: Everything you need to know about CureVac, the drugmaker working on a coronavirus vaccine that's at the heart of a Trump-Germany controversy
This is a developing story and will be updated.
NOW WATCH: What's inside these 8 unique creatures
See Also:
- Everything you need to know about CureVac, the drugmaker working on a coronavirus vaccine that's at the heart of a Trump-Germany controversy
- The first trial of a potential coronavirus vaccine just started in Washington state. It will take at least a year to know if the vaccine works.
- Hospitals across the US are canceling procedures to make room for a potential surge of coronavirus patients
JOIN OUR PULSE COMMUNITY!
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng